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Barriers and facilitators to the adoption 
of electronic clinical decision support systems: 
a qualitative interview study with UK general 
practitioners
Elizabeth Ford1*, Natalie Edelman1,2, Laura Somers1, Duncan Shrewsbury1, Marcela Lopez Levy3, 
Harm van Marwijk1, Vasa Curcin4 and Talya Porat5 
Abstract 
Background: Well-established electronic data capture in UK general practice means that algorithms, developed on 
patient data, can be used for automated clinical decision support systems (CDSSs). These can predict patient risk, help 
with prescribing safety, improve diagnosis and prompt clinicians to record extra data. However, there is persistent evi-
dence of low uptake of CDSSs in the clinic. We interviewed UK General Practitioners (GPs) to understand what features 
of CDSSs, and the contexts of their use, facilitate or present barriers to their use.
Methods: We interviewed 11 practicing GPs in London and South England using a semi-structured interview sched-
ule and discussed a hypothetical CDSS that could detect early signs of dementia. We applied thematic analysis to the 
anonymised interview transcripts.
Results: We identified three overarching themes: trust in individual CDSSs; usability of individual CDSSs; and usability 
of CDSSs in the broader practice context, to which nine subthemes contributed. Trust was affected by CDSS prov-
enance, perceived threat to autonomy and clear management guidance. Usability was influenced by sensitivity to the 
patient context, CDSS flexibility, ease of control, and non-intrusiveness. CDSSs were more likely to be used by GPs if 
they did not contribute to alert proliferation and subsequent fatigue, or if GPs were provided with training in their use.
Conclusions: Building on these findings we make a number of recommendations for CDSS developers to consider 
when bringing a new CDSS into GP patient records systems. These include co-producing CDSS with GPs to improve fit 
within clinic workflow and wider practice systems, ensuring a high level of accuracy and a clear clinical pathway, and 
providing CDSS training for practice staff. These recommendations may reduce the proliferation of unhelpful alerts 
that can result in important decision-support being ignored.
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Introduction
The digital revolution has influenced many aspects of 
healthcare systems world-wide. United Kingdom (UK) 
based general practice (GP) has been at the forefront of 
this, with general practice patient notes moving in the 
1990s from paper to Electronic Health Records (EHRs), 
using systems such as TPP SystmOne [1], EMIS Health 
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[2], INPS Vision [3] and iSOFT [4]. Crucially, these are 
regulated and commissioned private companies that, 
like GPs, are contracted to deliver services to the NHS, 
but are not a core part of it, and thus have their own 
business models. Interoperability with the NHS is guar-
anteed by means of the GP IT Futures framework and 
the Accredited Services Register [5, 6]. This digitalisa-
tion means that all of the patient’s information is stored 
in one place, prescriptions can be sent to pharmacies 
electronically and many patients could access their 
healthcare records online at home if they so wished.
Data on patients’ demographics, clinical conditions 
and consultations are captured electronically, therefore 
they can be used to inform algorithms which could aid 
General Practitioners (GPs) in their consultations, risk 
assessments, diagnosis making, management choices, 
and safety netting [7, 8]. Known collectively as clinical 
decision support systems (CDSSs), these tools aim to 
perform a variety of functions and have different modes 
of delivery [9]. Some CDSSs exist as embedded tem-
plates that the GP can complete manually that come up 
without asking, while others are pre-filled, at the GPs’ 
request, with data previously recorded in the patient’s 
notes [10]. Some require activation by a clinician while 
others run automatically when a patient record is 
opened.
Most CDSSs perform one of the following functions: 
First, CDSSs can provide prescribing-based alerts (an 
inbuilt safety feature of EHRs). These pop-up messages 
remind prescribers to be cautious of prescribing medi-
cations to which the patient is known to be allergic, or 
prevent prescriptions being written if the patient is 
taking an interacting medication. Second, CDSSs can 
prompt clinicians to record important information in 
the patient’s EHR, in order to meet contractual require-
ments with the NHS (creating Summary Care Records, 
for instance), other set targets, such as the Quality and 
Outcomes Framework (QOF), or an electronic frailty 
index to assist the new frailty coding requirement [11]. 
QOF is a pay-for-performance scheme which aims to 
improve GP performance by offering financial rewards 
for practices who fulfil specific patient-centred criteria 
[12]. For example, practices are rewarded if their patients 
with diabetes have had appropriate reviews of glycaemic 
control within the last 12 months [13]. High quality data 
entry ensures records can be used to identify patients in 
need of a review for their condition or to create alerts on 
the patient’s home page to remind their GP to perform 
tasks such as measuring their blood pressure or glycated 
haemoglobin (HbA1C). Finally, CDSSs can indicate a 
patient’s risk of disease either currently (diagnostic) or 
in a pre-determined timescale (prognostic). For exam-
ple, the QRISK score determines cardiovascular disease 
risk over 10 years, designed to prompt GP intervention to 
reduce risk [14].
CDSSs can aid the GP with the management of both 
individual patients and their overall caseload [15, 16]. 
However, there is considerable evidence of low uptake 
and dissatisfaction with use in General Practice settings, 
pointing overall to problems with individual CDSS pur-
pose and delivery, and with how CDSSs interact with 
each other and the clinical context [17].
Many CDSSs remain un-implemented [18], despite 
extensive research into diagnostic CDSSs and the poten-
tial for these tools to improve patient outcomes [19]. The 
diagnosis gap for dementia in primary care provides one 
such exemplar case. Over 70 risk-prediction models for 
dementia have been developed [20] but none are cur-
rently used in UK general practice to aid GPs in picking 
up on patients at high risk of dementia, and around 34% 
of UK patients with dementia remain undiagnosed [21]. 
Although a dementia early detection or risk profiling tool 
may aid recognition of the condition in general practice, 
potential barriers to use of such tools include the likeli-
hood of a high number of false positives which may cause 
harm to patients, and the lack of ameliorative treatments 
following diagnosis [22].
Many CDSSs also go unused because they are time-
consuming for the GP to complete [23] and they see 
little additional benefit from completing them. While 
templates can collate information and provide useful 
explanations for patients [24], they may interrupt clinic 
workflow. The QOF scheme has been shown to improve 
patient outcomes for conditions like diabetes at a popu-
lation level [25] but a particular patient may not wish to 
answer additional question considered less relevant for 
their current reason-for-the-encounter, and the scheme 
can be associated with the need for more GP consulta-
tions per patient, which puts additional stress on an 
already over-stretched service [26]. Although prescrib-
ing alerts are designed to improve patient safety, they 
are likely to be overridden if they are annoying, unhelp-
ful, inefficient or irrelevant, or if the alert has not taken 
current patient context sufficiently into account [27, 28]. 
Further, due to the overwhelming presence of these, they 
are all too commonly dismissed without reading them 
[29], as the sheer volume of alerts in any given day can 
create the problem of alert fatigue [30]. Some of these 
issues above may explain why 49–96% of CDSS alerts are 
overridden or ignored [31].
Several commentators have described likely reasons for 
clinicians’ lack of engagement with CDSSs, suggesting 
that CDSSs have been developed with a poor match to 
clinical workflow, an excessive focus on interruptive noti-
fications resulting in alert fatigue, and overly simplistic 
logic that fails to capture nuances of patient presentation 
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or care [32, 33]. Primary care is basically reason-for-
the- encounter led, which can easily be perceived to be 
at odds with a digital CDSS population-based approach 
in the 9  min available for a consultation. GPs may feel 
they would need to adapt their consultation style to make 
use of a CDSS [10]. This suggests that developers take an 
inadequate focus on processes of care, clinician work-
flow, or the whole EHR system, when developing CDSSs.
Confirming this, a review on artificial intelligence 
(AI) in primary care indicated that only 14% of pub-
lished studies reporting development of AI diagnostic 
or treatment support algorithms had authors who were 
employed in primary care [34].
Together this evidence indicates that a variety of factors 
influence use of CDSSs, and that further contemporary 
qualitative research with UK GPs is warranted as a first 
step, particularly as the availability of CDSSs grow, their 
delivery evolves and a younger (and more fragmented) 
GP workforce emerges. In particular, low uptake and low 
perceived usefulness of CDSS by GPs indicates the need 
to align CDSS development to clinician needs and prefer-
ences, and the context in which they are delivered. This 
qualitative study was therefore conducted with the aim 
of supporting and optimising the design of future CDSSs 
by identifying factors that influence how or why GPs use 
these tools, looking specifically into aspects of CDSSs 
they find useful and problematic, both individually and in 
the wider context of their practice. The overarching aim 
was to ensure that CDSS design better accommodates 
and meets the needs of clinicians and the contexts in 
which they work.
Methods
The reporting of this study follows the COnsolidated cri-
teria for REporting Qualitative Studies (CORE-Q) [35].
Participants and recruitment
Participants were recruited by convenience sampling 
through contacts at Brighton and Sussex Medical School 
(BSMS) and King’s College London Faculty of Life Sci-
ences and Medicine. GP tutors or researchers at these 
medical schools were approached via email and in tutor 
planning meetings and invited to participate. To be eli-
gible for the study the participants had to be currently 
working in general practice. Theoretical saturation of 
the data, whereby no further themes were identified, was 
reached after analysis of the 7th interview and verified 
by 4 more interviews; as such the sample size of 11 was 
deemed to be sufficient [36].
Procedure
All interviews were conducted independently by a female 
freelance researcher (MLL) who holds a doctorate in 
Sociology, had extensive interviewing experience, and 
whom the participants had no relationship with, or 
knowledge of, prior to the interviews. Participants were 
interviewed by telephone or in a location convenient to 
them with reimbursement for any travel costs and for 
their time, no one else was present. The interview session 
began with the participants completing a demographics 
questionnaire followed by either signing a physical con-
sent form or giving verbal consent if being interviewed 
by telephone. The interviews followed a semi-structured 
protocol using a topic guide, with questions such as “Are 
there any particular features or functions that you like in 
these types of computer systems providing advice, rec-
ommendations or alerts?” The topic guide is supplied as 
Additional file  1. This topic guide was pilot tested with 
one of the lead researchers (DS) and comprised a series 
of open-ended questions regarding the GPs’ views on 
CDSSs. At the beginning of the interview, a hypotheti-
cal example of a dementia early detection tool was intro-
duced. This was chosen because there is a large body of 
work on developing automated dementia risk prediction 
work, some of which focuses on using primary care data 
[20, 37–42]. However, prediction or detection of demen-
tia is still controversial because of a lack of treatment 
available which makes any different to the disease trajec-
tory [43], because of the high risk of false positives [44], 
and due to the patient’s “right not to know” [45]. This 
context regarding a dementia-based CDSS was therefore 
explored throughout the interviews in order to give a 
focus and generate debate and discussion. All interviews 
were audio-recorded and transcribed verbatim by a third-
party service (Essential Secretary Ltd); these transcripts 
were not returned to the participants. No repeat inter-
views were performed, and no field notes were recorded.
Data analysis
We approached this analysis with a realist ontology and 
an objectivist epistemology. A thematic qualitative analy-
sis was performed on the 11 interview transcripts by one 
coder (LS) using NVivo 12 [46]. The data analysis pro-
tocol followed the thematic analysis step-by-step guide 
provided by Braun and Clarke [47]. Firstly, the coder 
familiarised herself with the data by reading all tran-
scripts thoroughly. The next step was to generate initial 
codes by highlighting parts of transcripts relevant to the 
study aims and tagging these to emerging codes. This 
was an iterative process, first coding a few transcripts, 
following which the codes were identified, named and 
defined, and a coding tree was produced, then the next 
few transcripts were analysed, to seek confirmation of 
initial codes and search for new ones. After 7 transcripts 
were analysed, no new codes or themes emerged. The 
coding structure was then evaluated by the study team 
Page 4 of 13Ford et al. BMC Med Inform Decis Mak          (2021) 21:193 
(LS, EF, NE and TP) and codes were combined to form 
refined themes, which were derived from the data rather 
than specified in advance. The interview transcripts were 
then reanalysed looking for any further evidence of the 
themes identified. The study team once more discussed 
and refined the theme structure, to map it most closely 
onto the study aims. The participants were not asked to 
provide feedback on the findings from the data.
Results
In total, 13 participants were interviewed, however, data 
from only 11 participants is included in this analysis as 
1 GP refused to be recorded and 1 interview record-
ing failed. The participants varied in age, role and other 
demographic factors as shown in Table 1 below. Regard-
ing EHR use; 7 of the participants used EMIS Web, 3 used 
SystmOne and 1 was unknown. Interview time ranged 
from 22 to 53 min with a mean duration of 35 min.
Analysis of the 11 interviews led to the identification of 
nine themes organised across the following three over-
arching themes:
• Trust in individual CDSS
• Usability of CDSS in consultation context
• Usability of CDSS in broader practice context
Figure 1 illustrates how each of the nine themes relates 
to one or more of these over-arching themes, following 
which a description of each theme is given. Quotes are 
given that were determined to best illustrate the emer-
gent theme.
Overarching theme 1: trust in individual CDSSs
Trust can be defined as “a feeling of certainty that a per-
son or thing will not fail”, [48] or as an “attitude that an 
agent will help achieve an individual’s goals in a situation 
characterised by uncertainty” [49], and this trust, or lack 
of it, mediates between people and their use of automa-
tion such as CDSSs. Trust in CDSSs can be developed by 
understanding what the origins of the technology and its 
outputs are, and learning over time whether the tool and 
its recommendations have a good fit to clinical workflow 
and context, and fit with clinicians’ self-view of their role 
in the clinic. These facets of promoting trust in CDSS are 
described below.
Provenance and transparency
The first theme affecting GPs’ trust in CDSS was the 
tools’ provenance, i.e. its origins and the means by which 
it was developed; together with how transparently this 
information was available. Poor uptake was associated 
with a lack of knowledge about the research underpin-
ning its development:
“They’re inherently distrustful of anything that 
hasn’t got somebody saying ‘oh I’ve done this trial 
and this trial and we’ve used it’ and I think that’s 
what we’ve been taught at medical school; to be scep-
tical until we’ve got the evidence.” – P06
Some participants suggested GPs were more likely to 
pay attention to an alert generated by a member of staff 
than an automated computer-generated alert:
“I think it’s just that you, you feel like actually some-
one’s thought about that, you know, and it’s a clini-
cian who’s thought about it rather than it just being, 
you know, automatically raised and may not actu-
ally be relevant to the patient.” – P04
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CDSSs that other GPs or practices had found useful 
and had recommended were more likely to be trusted 
and used. This suggests the importance of the tool align-
ing to clinical workflow and of GP involvement in tool 
design and dissemination, as if another GP has found 
it useful and endorsed it, a new GP is more likely to be 
ready to try it:
“I think there is a degree of sharing these kind of pro-
tocols and algorithms amongst GP practises and we 
certainly, you know, GPs talk to each other and say 
‘oh yeah we’ve got this thing that alerts for that par-
ticular problem’, ‘oh, have you? Right great can we, 
can we bring it in?’.” – P06
Threat to autonomy and skills
Participants’ feelings of distrust in CDSS reflected a con-
cern that such tools represented a threat to GPs’ knowl-
edge and autonomy by ‘questioning’ the accuracy and 
decision-making skills of practitioners:
“I think we don’t like using it because we think we’re bet-
ter than computers.” – P05.
However, some GPs acknowledged that the CDSS 
could add value to their practice:
“…there is an element of arrogance to that which is 
saying that we know better than all of these algo-
rithms and things...” – P06
CDSSs were perceived as useful and less threatening 
where they acted as an aid-memoire to ensure all aspects 
of assessment were incorporated:
“I use a menopause one. It will … remind you of eve-
rything you should be asking in that consultation, so 
it’s a little bit like consultations for monkeys I sup-
pose, but really a help, actually a helpful aide-mem-
oire.” - P05
“We really do like those prompts in a patient with 
diabetes where there are 17 things to do and I’ve just 
missed out two or three of them, so it’s really nice to 
have somebody say ‘oh don’t forget there’s the urine 
test and you haven’t yet sent the patient for the eye 
test that you thought somebody else was doing and 
it looks like nobody’s done after all, so maybe get that 
done’.” – P02
Alerts were particularly welcomed, and less likely to 
be perceived as a threat, when they were developed as 
a result of requests by GPs to improve practice, rather 
than imposed on GPs from an unknown or non-clinical 
source:
“The GPs themselves were asking for an alert, and 
the alert was, in pregnancy, second, third trimes-
ter to give the pertussis vaccine and because the 
GPs were asking for that prompt and wanted to be 
reminded and didn’t want anybody to slip through 
the net, they all took really good notice of it.” – P02
Clear communication and management guidance
This theme related to two over-arching themes—Trust in 
individual CDSS and Usability of individual CDSS. One 
of the most frequently discussed topics was the impor-
tance of the CDSS outcome being simple to explain to 
patients. A frequently-given example was the QRISK 
1 Trust in individual CDSS
2 Usability of individual CDSS
3 Usability of CDSSs in broader 
practice context 
1.1 Provenance and Transparency 
1.3 Clear communication and management 
guidance 
1.2 Threat to autonomy and skills
2.1 Sensitivity to patient context
2.2. User control and flexibility
2.3 Intrusiveness
3.2 Training and Support
3.3 Practice-wide focus
3.1 Alert proliferation and fatigue
Fig. 1 Coding tree detailing the themes and subthemes
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pictogram demonstrating the patient’s risk in an easy-to-
understand form that explains the necessity of treatment:
“It actually comes up with a nice diagram that it 
can use with your patients that’s got smiley faces of 
different colours to illustrate risk … it’s just a differ-
ent way to help augment that communication with 
them. For things like that it’s quite helpful because 
patients are wary of tablets, quite rightly. They don’t 
quite understand ‘oh, what does it mean that I’ve got 
a 20% risk of, of an event within the next 10 years’, 
you’re like, ‘well actually in a crowd of people if we 
were to revisit them in 10 years’ time two of them 
would have had a heart attack’ or something like 
that, it, it’s just helpful.” – P03
Having a clear and easy-to-understand outcome was 
not only a feature that is beneficial to patients, it could be 
important to the GP. Tools that converted inputted data 
into an easy-to-follow management plan (e.g. the ‘Sick 
Child Template’) were perceived as useful:
“It’s got a kind of column of green things, a col-
umn of orange things and a column of red things. 
Then there’s a really clear next page about what 
you should do if they’re kind of, if they’ve got lots 
of greens, you know, what the process would be if 
they’ve got lots of reds in terms of, you know, one side 
and I think that’s really helpful just because it kind 
of combines the data you’re putting in with actually 
a useful plan.” – P04
Overarching theme 2: usability of individual CDSS
Usability is ‘the extent to which a product can be used 
by specified users to achieve specified goals with effec-
tiveness, efficiency, and satisfaction in a specified con-
text of use’ [50]. Usability was influenced by whether the 
CDSS effectively supported the decisions of the GP, or 
conversely if the CDSS was ignorant to the patient con-
text and therefore inaccurate. CDSSs were perceived as 
efficient if they supported the GP’s decision-making in 
a non-intrusive and flexible way, and user satisfaction 
could be understood as whether the GP found the CDSS 
as a good fit to their workflow, or conversely found it 
frustrating. These facets of usability are explored in the 
three sub-themes described below.
Sensitivity to patient context
Although under overarching theme 2, this theme also 
relates to Trust in Individual CDSS and encompasses 
both the accuracy and appropriateness of the CDSS to 
give useful decisions. The additional contextual infor-
mation that a GP, but not a CDSS, is privy to, will affect 
the accuracy of the tool output. This led GPs rightly to 
question the sensitivity and specificity of individual 
CDSS, as illustrated in this example:
“I had a patient…who scored very poorly in the … 
cook-book scoring system [for diagnosing memory 
problems]. If she was doing that online she’d have 
been sent off to a memory clinic but actually she was 
severely dyslexic… she’s never been good with being 
able to tell the time.” – P10
Also mentioned was the GP’s familiarity with the 
patient and the benefit of observation during face to face 
visits:
“A lot of the patients who I kind of see regularly with 
chronic problems, I kind of know if they’re well or 
not because I know the patient and I just can tell if 
they’re themselves or if they’re not because you have 
a constant, you know, you lose that with a computer.” 
– P04
“… I can tell… in the three-metre walk from the wait-
ing room to my consultation room whether I’m going 
to send the child into hospital or not because I can 
just see if they look well or not.” – P04
Additionally, GPs discussed problems with not only 
CDSS accuracy but with appropriateness in the broader 
clinical care of each patient. Once again, participants 
described how the computer cannot take account of 
social cues or the wider patient context within the con-
sultation. One participant raised this in relation to 
dementia diagnosis:
“Actually, if that patient is, you know, probably in 
the last six months of their life, or they’re falling 
over all the time, or they’re getting really confused 
with their medications, it might be completely inap-
propriate and then you’ve got just a whole world of 
paperwork and alerts that actually aren’t relevant 
because it’s the computer system that’s making you 
do it.” – P04
Participants also noted the negative physical and 
emotional impacts on the patient of unnecessary 
investigation:
“The problem comes in where….it leads to over-
investigation of a patient” – P09
“Now, how is a patient going to feel if I’m doing their 
diabetes check and then up pops ‘this patient may 
have dementia … please test’, then that’s immedi-
ately going to get them pretty worried” – P02
Similarly, one respondent noted that both screening 
and diagnosis are only important to carry out where the 
patient will benefit as a consequence; this was particu-
larly mentioned in relation to dementia screening:
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“The worst thing you can do is to have an earlier 
diagnosis but there’s no services anywhere that, 
there’s no psycho-geriatric elderly mental health 
care services to refer the patient into, so you’re just 
suddenly creating this demand with no potential 
outlet and that really increases frustration.” – P02
User control and flexibility
Usability was also improved by flexibility in the presen-
tation of the CDSS, e.g. the option to dismiss it or leave 
certain fields incomplete. GPs explained that this allowed 
them to be in control of CDSSs rather than feel con-
trolled by them. This came up firstly in relation to tem-
plates requiring information irrelevant to a particular 
consultation:
“If it’s optional it’s not a problem. I think there have 
been templates designed before that you have to 
enter everything and that’s very frustrating.” - P01
“I think it feels frustrating … when the system is so 
process-driven that there’s no sort of autonomy of the 
GP to, you know, change it or, kind of, put in what’s 
relevant.” – P04
Similarly, GPs expressed frustration at being unable to 
alter the outcome of some CDSSs:
“You can click ‘escalation not appropriate’, but then 
it automatically codes sepsis or something in the 
notes and you can’t do anything about that.” - P08
Frustration was also expressed that some CDSSs 
required description of actions taken after consultation, 
using inflexible options, leaving GPs the choice to record 
falsehoods or leave an audit trail in which they felt they 
might be culpable:
“… in order to dismiss it you have to select what 
action you’ve taken such as, well have you called 
an ambulance, have you sent them into hospital…
you’re then panicking thinking gosh I don’t want, I 
don’t want to lie, no I haven’t sent them into hospital 
but is that a judgement, is that them saying because 
I haven’t done that I’m a rubbish doctor?”- P03
Generally, CDSS flexibility and control was valued as 
a means of maintaining GP autonomy, linking ability to 
control the functions of the CDSS with control of making 
the best decisions for individual patients:
“And I think what the clincher is…it’s seen to be 
something that the GP is leading or … is it imposed 
upon the GPs... The computer is there to support the 
role of the doctor and not in any way to takeover.” – 
P02
Intrusiveness
The intrusiveness of CDSSs was perceived variously 
as helpful and unhelpful. Two participants particu-
larly highlighted the potential usefulness of dementia 
screening tools due to difficulties in assessment and 
early diagnosis:
“Something like dementia you do want to identify 
it early, and actually in terms of dementia I think 
it would be helpful to have a decision aid because 
at the moment it’s, it’s not very easy to assess 
patients for dementia.” – P01
“… making the diagnosis actually can be really 
helpful because it gives a kind of rationale and it 
gives a reason for, you know, the symptoms the per-
son might have, and it can give access to support if 
then you’ve got a diagnosis of dementia” – P04
Conversely, CDSSs were perceived as an unwelcome 
intrusion where they raised an issue which the GP felt 
to be unimportant within that particular consultation. 
The “agenda” of the consultation may be determined by 
the patient or the GP, but where an alert presents which 
does not relate to a topic of importance for either party 
in the consultation, it may be perceived as undermining 
of the GP’s professional expertise and would be unlikely 
to be used:
“So, if it seems to address the GP’s own agenda 
then maybe they’ll take notice, if it doesn’t then 
they’ll find them deeply de-professionalising, and 
concentrate on the patient in front of them and not 
the computer screen in front of them.” - P02
Given the time-pressured environment that the GPs 
work in, self-population of CDSS fields using previ-
ously-recorded data (e.g. in QRISK) was viewed as a 
benefit which reduced intrusiveness:
“So, by the time you open the tool, you might only 
have to … click a couple of boxes and then you’re 
done.” – P09
Conversely, poor integration of individual CDSSs into 
the computer system created difficulty when data was 
requested that could not be accessed without closing 
the CDSS template:
“You can’t go looking in the notes, you can’t input 
anything else, this is now taking priority, so you 
either suspend it and then re-open it and suspend 
it and re-open it, which is just a hassle.” – P05
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Overarching theme 3: usability of CDSSs in the broader 
practice context
This overarching usability theme considered CDSSs 
beyond their individual features. Each CDSS exists in 
the context of multiple competing CDSSs and other 
alerts, templates and forms, that can influence their 
uptake and use.
Alert proliferation and fatigue
Intrusive alerts were frustrating on their own, but in the 
context of the proliferation of multiple intrusions and 
alerts, participants described experiencing “alert fatigue”. 
This was the cumulative and distracting effect of multiple 
competing demands coming from the computer system:
“In general practice you might have the reception-
ist sending you an instant message, you might have 
a notification coming from the practice team, you 
might have a task coming through that a prescrip-
tion needs to be done, so you might have four or five 
pop ups anyway.” – P05
In particular, their distracting effect was seen to nega-
tively affect patient-doctor rapport:
“It really is like an interruption, you know, no GP 
wants somebody to just burst in with the door open-
ing or the phone ringing. In the same vein no GP 
really wants a big thing to just pop up on the screen 
that they didn’t call up.” – P01
“And then the patient is talking to you and I have 
had to say… ‘I’m really sorry but I was distracted by 
the messages popped up on my screen and can you 
please tell me about it again’.” – P05
Having to handle the constant distractions from mul-
tiple sources meant the GPs had to attempt to multitask, 
which they considered to present a patient safety risk:
“So, you’re confronted with that need to sort of 
multi-task which isn’t safe… I think most people 
can’t really safely multi-task especially when you’ve 
got actual decisions that you’ve got to make.” – P03
The proliferation of alerts led to participants becoming 
desensitised to alerts, with GPs overriding or dismissing 
them:
“You get into a habit and it, it’s something that we 
all joke about professionally, you get into a habit of 
just dismiss, dismiss and click on the X, or find some 
way, you don’t even read it properly now.” – P03
“Because I think we get to the point where we get so 
bombarded and overwhelmed with stuff that we just 
start to switch off from these computer alerts, you 
know”– P10
This fatigue could also cause GPs to miss important 
alerts, with ramifications for patient safety:
“You end up getting so many alerts that it’s very dif-
ficult to see the woods for the trees with them.” – P06
“I prescribed Trimethoprim for somebody and didn’t 
notice an alert, I must have dismissed it, that said 
they were allergic to Trimethoprim, and it was only 
the pharmacist calling up saying did you realise, you 
didn’t mean that did you?” – P03
Training and support
Training and support emerged as a key theme related to 
both usability of individual CDSSs and their general use 
in the overall practice context. Firstly, training needs 
were perceived to differ by age and to be related to overall 
confidence with information technology:
“I think to a certain extent there is a bit of a cul-
tural change in the sense that the newer generation 
of doctors coming through are much more used to 
computers telling them things in their own lives and 
so they’re much more accepting of the idea that the 
computer might give them helpful information.”- P06
GPs often felt irritated that new tools or system updates 
were added but with no explanation of how best to use 
them:
“I suppose my, my biggest bug bear is training, if any-
thing new comes in it then needs to be disseminated 
to everybody who’s using the system, which often 
doesn’t happen.” – P05
Related to this, GPs described that many CDSSs were 
incorporated into EHRs but could get ‘lost’ amongst 
other system features without adequate training:
“You know and that’s how I enter it into the notes 
that I’ve, that I’ve calculated it rather than using the 
internal scoring system which EMIS ... probably has, 
I just haven’t found it yet.”- P10
Familiarity with not just information technology over-
all, but the individual tool itself was seen to improve 
uptake:
“I think if you’re very familiar with a, with a tem-
plate then you can probably use it all the time and it 
probably does speed things up”- P07
Practice‑wide focus
CDSS use which operated at the broader practice level 
was seen as a helpful endeavour when still controlled by 
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the practice or GP, in order to generate lists of possible 
missed diagnoses or patients who should be screened for 
particular conditions:
“I think there’s some people who really clearly fall 
into the category you know even sort of middle ones, 
but sometimes people do get missed… I think some-
times having an automated system plus the option 
for GPs whether to add patients to that list.” – P04
“Overall, I think GPs have an important role in 
improving public and population health, and even if 
we did, say, okay, these 5% of patients may be at risk 
of dementia, we need to do this work and call them 
in and try to diagnose the dementia earlier, that will 
be better for the population’s health going forward.” 
– P01
Practice control of list generation (as opposed to auto-
matically-generated CDSSs popping-up during consul-
tation) was seen as an important means of keeping GP 
workloads at manageable levels:
“That would just mean that as a GP you’ve then got 
to kind of go and do, you know, a mental state, cog-
nitive state, exam on every patient who says they 
might have dementia which would just kind of cre-
ate workload and when are you going to do that?” 
– P04
Discussion
We have identified features of CDSSs, individually and 
in the broader practice context, which promote or hin-
der their uptake by GPs in the UK. Our results suggest 
that many previous CDSSs have not been designed with 
the end user, practice context or clinical workflow at the 
forefront, and thus remain difficult to use. Commercial 
interests may also play a role here due to the NHS pur-
chase/provider split. There is thus substantial room for 
improvement in the development and implementation of 
these tools. First of all, results suggest it is important that 
the provenance of the CDSSs is congruent with sources 
which are esteemed as trustworthy or scientifically cred-
ible by the GP and that this provenance should be easily 
accessible to GPs. Similarly, CDSSs’ accuracy was valued, 
particularly when identified through robust validation 
studies, which had taken account of the broader patient 
context. GPs perceived CDSSs to be most useful when 
they provided clear guidance on actions to be taken fol-
lowing use; this could take the form of a clinical guideline 
or pathway, or a communication aid for discussing next 
options with the patient.
Participants described that CDSSs needed to be tech-
nically well integrated into their patient record systems, 
and be designed to both reduce manual information 
entry (e.g. by harvesting it automatically from the patient 
record) and be flexible enough to be dismissed when the 
pop-up was out of context. CDSSs which needed to be 
manually filled in, but which blocked out access to the 
patient record while open, were especially difficult to use 
and disliked by GPs.
Practitioners described wanting CDSSs to assist, rather 
than dictate, their clinical practice, so as not to be a threat 
to their autonomy. GPs did not want to feel de-profes-
sionalised by the computer over-riding their decisions 
or intruding where it was not appropriate; where this 
happens, it may indicate that tools are poorly developed 
and tested. It was observed that GPs could have complex 
views on CDSSs, as pop-up reminders and guidance on 
decision-making were experienced as both helpful and 
problematic, depending on the context of the individual 
consultation (how the patient presented, and the compet-
ing agendas of patient, clinician and CDSS), who initiated 
the request for the CDSS, and on the degree of prolifera-
tion. These perhaps in part reflect – and are solved by 
– integration of CDSSs and practice-level training, the 
latter also providing an opportunity to present the tool’s 
provenance and evidence for its accuracy. Many GPs 
indicated that CDSSs appeared in their systems with no 
training or support on how to use them, which meant 
that they only learned how to disable them, rather than 
engage with them fully and utilise them to their best 
potential. Results also indicate the need to involve GPs 
and other practice staff in CDSSs design, in order to pre-
vent CDSSs being perceived as a threat, but rather to be 
seen as a tool complementing practitioner’s knowledge 
and autonomy.
The GPs in our study acknowledged that screening and 
risk profiling tools could help to pick up cases of impor-
tant diseases such as dementia, but were wary of over-
diagnosis, over-investigation of ultimately well patients 
or diagnosis and screening inappropriate in the context 
of a given patient’s co-morbidities or other life challenges. 
They viewed this excessive intervention as a potential 
source of patient harm. This intersects with the need for 
high accuracy in tools and also flexibility to decline tool 
use, for example in the given example of a patient in the 
end-stages of life. GPs felt that CDSSs which could com-
pile concise patient lists of people who warranted further 
investigation for diagnosis or preventative care might be 
helpful in the wider practice context.
Findings in the broader research context
Previous work investigating clinicians’ adoption or non-
adoption of CDSSs has shown a range of similar problems 
causing low uptake of tools in the clinic, such as templates 
being time-consuming to complete [23], poor training on 
using alerts [9, 51, 52] alerts being over-ridden [29, 31] or 
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irrelevant [28] and clinicians being fatigued by the sheer 
number of alerts [30, 32]. Other studies have found that 
practice list-size was consistently associated with uptake 
of technology, with larger practices more inclined to use 
CDSSs [53], and that GP involvement in the creation of 
the CDSSs led to feelings of ownership of the technology 
and increased use of the system [17]. Similar to our study, 
previous work with UK GPs found that limited IT skills, 
problems in understanding the output of CDSSs, and dif-
ficulty communicating the results of the CDSS to patients 
discouraged use, and that perceived usefulness, perfor-
mance, trust in the knowledge base, and ease of use were 
all factors which influenced GPs’ intention to use CDSSs 
[17, 54].
Other research has proposed frameworks for under-
standing the low uptake of CDSSs. An American study 
suggested that speed of use, real time delivery, fit to clini-
cal workflow, and ease of usability would all augment use 
of a CDSS, whereas CDSSs which asked clinicians to stop 
performing a usual clinical activity (because of lack of 
evidence of benefit) were often overridden, and CDSSs 
which were complex, fell out of date, or asked for a lot of 
additional information, were disparaged [55]. However, 
this list of “commandments” for CDSS development was 
developed with an American clinical workforce in mind 
and therefore may not translate well to UK clinical prac-
tice. Greenhalgh et  al.’s Non-Adoption, Abandonment, 
Scale-up, Spread and Sustainability (NASSS) framework 
may be relevant for the UK context, and suggests that 
only when the CDSS tackles a “simple” condition, has 
excellent usability, with little need for training or trouble-
shooting, and generates value for clinicians or patients, 
will it be adopted and scaled up in practice [18]. This 
maps on generally to our findings which suggested that 
non-intrusiveness, an actionable clinical outcome and 
little need for training were all features which facilitated 
adoption of a CDSS.
Strengths and limitations
Previous research has looked at likely reasons for clini-
cians’ poor engagement with CDSSs, but this is one of the 
first studies that has aimed to identify features of CDSS in 
UK general practice in order to inform the future devel-
opment of these tools to ensure uptake and fitness for 
purpose. However, this is a small qualitative study, and 
thus provides recommendations which can be further 
explored in more structured quantitative work, rather 
than definitive results. One of the limitations of this study 
was the sampling strategy, which was to approach GPs 
who were working within two UK medical school net-
works, rather than identifying GPs practicing across a 
more representative geographical spread. This resulted in 
the sampling being mainly part-time GPs, many of whom 
had an interest in medical education and were in younger 
age groups (30–39). Younger doctors may be more 
accepting of automated CDSS than older practitioners. 
A wider sample of older or full time GPs with no links 
to medical schools may have given different opinions, 
and we cannot declare our results reached saturation of 
information from the full range of GPs, although satura-
tion of themes within our particular sampling strategy 
was reached. Of note, interviewing, coding of transcripts 
and theme refinement were carried out by different team 
members. This has both advantages and disadvantages. It 
may allow the analysis to be more data-led than a study 
conducted by a single researcher, where bias may be 
more likely to occur, but a single researcher who brings 
knowledge or expertise in the area can achieve deeper 
understanding of the data by seeing the process through 
from beginning to end.
Implications for future CDSS development
This rich exploration of GPs’ views on features of CDSSs 
that enhance their usability and trustworthiness, allows 
us to make tentative suggestions for considerations dur-
ing CDSS development in the future. Importantly, these 
recommendations address both intrinsic and technical 
features of individual tools, and the wider clinical context 
in which multiple CDSSs, multiple demands on GPs and 
multiple personal issues and morbidities must be better 
accounted for in design. Individual CDSSs must be devel-
oped with a systems approach (taking into account the 
whole context) rather than just a product approach which 
focuses only on the development of the specific product 
without relating to the bigger picture and the influence 
of the product on other linked issues (e.g., other systems, 
context of use, and other stakeholders).
We recommend that developers of new prediction, 
risk-profiling or prescribing safety tools for use in UK 
primary care patient record systems consider all the 
domains shown in Table  2 alongside corresponding 
recommendations.
Conclusions
CDSSs that increase evidence-based decision making in 
healthcare have the potential to improve quality of care 
and patient health and outcomes, but will only be of ben-
efit if used widely in clinical environments. Many tools 
currently available in UK general practice record systems 
have been conceived and designed with scant regard for 
usability principles and clinician input, and, as a result 
of this, are deemed not fit-for-purpose by the users and 
do not fit with clinician workflow or multi-disciplinary 
working (such as between primary care and clinical 
pharmacy). US-based research suggests alerts may even 
contribute to GP burnout rates [56]. An overemphasis 
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on individual CDSSs design appears to pay scant atten-
tion to both the patient context and the clinical context, 
which includes the existence of multiple CDSSs which 
at times ‘compete’ for clinician attention. This can result 
in a proliferation of alerts resulting in none of the tools 
having their desired impact. We have described a set of 
recommendations which, if used when each new tool is 
developed, could rapidly increase the usability and real-
world effectiveness of these tools. It is clear from this 
work that clinician involvement in individual tool design 
is vital, and that as more and more tools are developed, 
methods for prioritising the most important ones in any 
consultation may also be needed, to reduce alert fatigue. 
Individual design must take account of both consultation 
context and dynamics but also the broader technological 
context by adopting a systems approach to design. We 
hope that further development and potential adoption of 
these suggested recommendations will increase the scru-
tiny and quality of new CDSSs coming to GP electronic 
health record systems and will contribute to enhanced 
patient care in the age of digital health.
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Table 2 Recommendations for further investigation
Domain Recommendation
Provenance and Transparency Supply the CDSS alongside an accessible and signposted evidence-base
Threat to autonomy and skills Include GPs in the development of the tool so it is aligned to their clinical needs and workflow and so that they can 
recommend it to their peers
Clear communication and 
management guidance
For any prediction given by the tool, provide an evidence-based management or care guideline for the clinician to 
follow
Supply visual communication aids, co-designed with patients, so that clinicians can communicate the outcome of the 
tool with their patients easily
Sensitivity to wider context Only release a new tool widely when validation of accuracy, and study of unintended consequences, has occurred in 
real world settings
Consider and evaluate contextual effects on accuracy such as age, frailty, and multi-morbidity
Ensure balance of false positives to false negatives given by tool is appropriate for resource use and does not result in 
excess harm
User control and flexibility Allow GP to maintain control, override or dismiss a tool
Ensure there is a provision to record wider context rationale for over-riding tool use
Integrate tool appropriately with EHR and ensure self-population from previously recorded data as much as possible
Intrusiveness Consult with GPs on appropriate balance between having a self-generating pop-up or having a template which can be 
called up by the GP
Alert proliferation and fatigue Consider the new tool in the context of all other tools within the system. Is this one really adding value?
Consider developing technologies which manage multiple tools or prioritise the most important alerts and suppress 
the rest
Consider a learning system which learns from the behaviour of GPs and accumulated evidence of the effectiveness of 
the different tools and alerts to adapt tools’ behaviour
Training and support Label and signpost online training available for using the tool within the tool itself, e.g. a video showing how it works 
and how to get the most from it and personalise settings where appropriate
Sustainability: How expensive and adequate is the support for the tool and will it still be provided over time?
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